Clinical trial
The Effect of Carvedilol Rapid Up-Titration in Patients With Heart Failure With Reduced Ejection Fraction (Biomolecular and Clinical Study on IL-6, TNF-α, NT-ProBNP, MDA, LVEF, 6MWT, and KCCQ)
NCT05179070 is registered in ClinicalTrials.gov with Universitas Sebelas Maret as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Carvedilol Rapid Up-Titration in Patients With Heart Failure With Reduced Ejection Fraction (Biomolecular and Clinical Study on IL-6, TNF-α, NT-ProBNP, MDA, LVEF, 6MWT, and KCCQ)
- Lead sponsor
- Universitas Sebelas Maret
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 10, 2021
- Completion date
- March 30, 2022
- Enrollment
- 26 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure with reduced ejection fraction hfref